These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 3129743)

  • 1. Localization of brainstem sites which mediate alfentanil-induced muscle rigidity in the rat.
    Weinger MB; Cline EJ; Smith NT; Blasco TA; Koob GF
    Pharmacol Biochem Behav; 1988 Mar; 29(3):573-80. PubMed ID: 3129743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brain sites mediating opiate-induced muscle rigidity in the rat: methylnaloxonium mapping study.
    Weinger MB; Smith NT; Blasco TA; Koob GF
    Brain Res; 1991 Mar; 544(2):181-90. PubMed ID: 2039935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of the nucleus raphe pontis and the caudate nucleus in alfentanil rigidity in the rat.
    Blasco TA; Lee D; Amalric M; Swerdlow NR; Smith NT; Koob GF
    Brain Res; 1986 Oct; 386(1-2):280-6. PubMed ID: 3096494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 'Catatonia' produced by alfentanil is reversed by methylnaloxonium microinjections into the brain.
    Amalric M; Blasco TA; Smith NT; Lee DE; Swerdlow NR; Koob GF
    Brain Res; 1986 Oct; 386(1-2):287-95. PubMed ID: 3022882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A role for CNS alpha-2 adrenergic receptors in opiate-induced muscle rigidity in the rat.
    Weinger MB; Chen DY; Lin T; Lau C; Koob GF; Smith NT
    Brain Res; 1995 Jan; 669(1):10-8. PubMed ID: 7712151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ketanserin pretreatment reverses alfentanil-induced muscle rigidity.
    Weinger MB; Cline EJ; Smith NT; Koob GF
    Anesthesiology; 1987 Sep; 67(3):348-54. PubMed ID: 3115150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elucidation of dose-effect relationships for different opiate effects using alfentanil in the spontaneously ventilating rat.
    Yang PK; Weinger MB; Negus SS
    Anesthesiology; 1992 Jul; 77(1):153-61. PubMed ID: 1609989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dexmedetomidine, acting through central alpha-2 adrenoceptors, prevents opiate-induced muscle rigidity in the rat.
    Weinger MB; Segal IS; Maze M
    Anesthesiology; 1989 Aug; 71(2):242-9. PubMed ID: 2569282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atipamezole, an alpha 2 antagonist, augments opiate-induced muscle rigidity in the rat.
    Weinger MB; Bednarczyk JM
    Pharmacol Biochem Behav; 1994 Nov; 49(3):523-9. PubMed ID: 7862703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of central mu, delta-1, and kappa-1 opioid receptors in opioid-induced muscle rigidity in the rat.
    Vankova ME; Weinger MB; Chen DY; Bronson JB; Motis V; Koob GF
    Anesthesiology; 1996 Sep; 85(3):574-83. PubMed ID: 8853088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antagonist effects of beta-funaltrexamine and naloxonazine on alfentanil-induced antinociception and muscle rigidity in the rat.
    Negus SS; Pasternak GW; Koob GF; Weinger MB
    J Pharmacol Exp Ther; 1993 Feb; 264(2):739-45. PubMed ID: 8437122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intracranial pressure increases during alfentanil-induced rigidity.
    Benthuysen JL; Kien ND; Quam DD
    Anesthesiology; 1988 Mar; 68(3):438-40. PubMed ID: 3125768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nitrous oxide produces a biphasic effect on opiate-induced muscle rigidity in the rat.
    Chang NJ; Weinger MB; Dyck JB
    Pharmacol Biochem Behav; 1995 Mar; 50(3):351-8. PubMed ID: 7617673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methylnaloxonium diffuses out of the rat brain more slowly than naloxone after direct intracerebral injection.
    Schroeder RL; Weinger MB; Vakassian L; Koob GF
    Neurosci Lett; 1991 Jan; 121(1-2):173-7. PubMed ID: 2020373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physiology of alfentanil-induced rigidity.
    Benthuysen JL; Smith NT; Sanford TJ; Head N; Dec-Silver H
    Anesthesiology; 1986 Apr; 64(4):440-6. PubMed ID: 3008595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fentanyl and alfentanil suppress brainstem pain transmission.
    Yuge O; Kitahata LM; Collins JG; Matsumoto M; Tabatabai M; Suzukawa M; Tanaka A
    Anesth Analg; 1985 Jun; 64(6):597-600. PubMed ID: 3923868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of different brain structures in the expression of the physical morphine withdrawal syndrome.
    Maldonado R; Stinus L; Gold LH; Koob GF
    J Pharmacol Exp Ther; 1992 May; 261(2):669-77. PubMed ID: 1578378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nucleus accumbens and amygdala are possible substrates for the aversive stimulus effects of opiate withdrawal.
    Stinus L; Le Moal M; Koob GF
    Neuroscience; 1990; 37(3):767-73. PubMed ID: 2247222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blockade by naltrexone of analgesia produced by stimulation of the dorsal raphe nucleus.
    Swajkoski AR; Mayer DJ; Johnson JH
    Pharmacol Biochem Behav; 1981 Sep; 15(3):419-23. PubMed ID: 7291246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opiate antagonists inhibit feeding induced by 8-OH-DPAT: possible mediation in the nucleus accumbens.
    Fletcher PJ
    Brain Res; 1991 Sep; 560(1-2):260-7. PubMed ID: 1836972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.